• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Y-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers.

作者信息

Rivoltini Licia, Bhoori Sherrie, Camisaschi Chiara, Bergamaschi Laura, Lalli Luca, Frati Paola, Citterio Davide, Castelli Chiara, Mazzaferro Vincenzo

机构信息

Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

HPB Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

出版信息

Gut. 2023 Feb;72(2):406-407. doi: 10.1136/gutjnl-2021-326869. Epub 2022 May 4.

DOI:10.1136/gutjnl-2021-326869
PMID:35508369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9872224/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/783c/9872224/d6a5f199d725/gutjnl-2021-326869f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/783c/9872224/d6a5f199d725/gutjnl-2021-326869f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/783c/9872224/d6a5f199d725/gutjnl-2021-326869f01.jpg

相似文献

1
Y-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers.肝细胞癌中的钇放射性栓塞诱导免疫反应，需要尽早使用多种检查点阻断剂进行治疗。
Gut. 2023 Feb;72(2):406-407. doi: 10.1136/gutjnl-2021-326869. Epub 2022 May 4.
2
Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma.钇-90放射性栓塞联合PD-1抑制剂治疗晚期肝细胞癌
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1799-1802. doi: 10.1007/s00270-018-1993-1. Epub 2018 May 29.
3
Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies.经肝动脉化疗栓塞术治疗后的肝细胞癌患者的放射性栓塞治疗。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1721-1730. doi: 10.1007/s00259-018-3968-5. Epub 2018 Mar 7.
4
⁹⁰Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT).肝脏放射性栓塞术（SIRT）后在混合型扫描仪上进行的⁹⁰Y飞行时间PET/MR检查。
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1744-5. doi: 10.1007/s00259-011-1792-2. Epub 2011 Apr 6.
5
Radioembolisation for treatment of pediatric hepatocellular carcinoma.放射性栓塞治疗小儿肝细胞癌。
Pediatr Radiol. 2013 Jul;43(7):876-81. doi: 10.1007/s00247-012-2568-y. Epub 2012 Dec 5.
6
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.不可切除肝细胞癌的治疗选择，重点是使用钇-90树脂微球的选择性内放射治疗（SIRT）
Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12972. Epub 2017 Jul 30.
7
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.钇 90 树脂微球放射性栓塞联合纳武利尤单抗治疗晚期肝细胞癌（CA 209-678）：一项单臂、单中心、2 期临床试验。
Lancet Gastroenterol Hepatol. 2021 Dec;6(12):1025-1035. doi: 10.1016/S2468-1253(21)00305-8. Epub 2021 Oct 23.
8
Radioembolisation of hepatocellular carcinoma patients using ⁹⁰Y-labelled microspheres: towards a diffusion of the technique?使用⁹⁰Y标记微球对肝细胞癌患者进行放射性栓塞治疗：该技术会得到推广吗？
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2114-6. doi: 10.1007/s00259-011-1952-4.
9
Imaging of Hepatocellular Carcinoma Response After Y Radioembolization.钇90放射性栓塞术后肝细胞癌反应的影像学表现
AJR Am J Roentgenol. 2017 Nov;209(5):W263-W276. doi: 10.2214/AJR.17.17993.
10
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.钇-90微球放射性栓塞治疗不可切除的肝细胞癌
Cochrane Database Syst Rev. 2016 Feb 16;2:CD011313. doi: 10.1002/14651858.CD011313.pub2.

引用本文的文献

1
Advances in radiation therapy for HCC: Integration with liver-directed treatments.肝细胞癌放射治疗的进展：与肝脏定向治疗的整合。
Hepatol Commun. 2025 Mar 21;9(4). doi: 10.1097/HC9.0000000000000653. eCollection 2025 Apr 1.
2
Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study.化疗和放射栓塞后肝内胆管细胞癌的肝移植：一项意向治疗研究。
Transpl Int. 2024 Oct 31;37:13641. doi: 10.3389/ti.2024.13641. eCollection 2024.
3
Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy.

本文引用的文献

1
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma.非终末耗竭的肿瘤驻留记忆 HBV 特异性 T 细胞反应与肝细胞癌无复发生存相关。
Immunity. 2021 Aug 10;54(8):1825-1840.e7. doi: 10.1016/j.immuni.2021.06.013. Epub 2021 Jul 15.
2
Systemic immunity in cancer.癌症的系统性免疫。
Nat Rev Cancer. 2021 Jun;21(6):345-359. doi: 10.1038/s41568-021-00347-z. Epub 2021 Apr 9.
3
CD8 T Cell Responses during HCV Infection and HCC.丙型肝炎病毒感染和肝癌过程中的CD8 T细胞反应
钇-90 诱导具有新抗原克隆型扩增的效应记忆反应：免疫治疗的意义。
Cancer Res Commun. 2024 Aug 1;4(8):2163-2173. doi: 10.1158/2767-9764.CRC-24-0228.
4
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications.肝细胞癌中肿瘤异质性与免疫逃逸机制的关联及其临床意义。
Br J Cancer. 2024 Aug;131(3):420-429. doi: 10.1038/s41416-024-02684-w. Epub 2024 May 17.
5
Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study.亚太地区肝细胞癌诊断、治疗与管理的真实世界数据：洞察研究
Liver Cancer. 2023 Oct 9;13(3):298-313. doi: 10.1159/000534513. eCollection 2024 Jun.
6
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.经动脉化疗栓塞术联合帕博利珠单抗治疗肝细胞癌的安全性和初步疗效：PETAL 期 Ib 研究。
Clin Cancer Res. 2024 Jun 3;30(11):2433-2443. doi: 10.1158/1078-0432.CCR-24-0177.
7
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma.帕博利珠单抗联合钇[90Y]树脂微球栓塞治疗预后不良的肝细胞癌的初步研究。
Oncologist. 2024 Mar 4;29(3):270-e413. doi: 10.1093/oncolo/oyad331.
8
Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility.经动脉放射性栓塞联合阿替利珠单抗和贝伐单抗治疗中晚期肝细胞癌：安全性和可行性的初步报告
J Interv Med. 2023 Sep 28;6(4):187-193. doi: 10.1016/j.jimed.2023.09.002. eCollection 2023 Nov.
9
Liver-Directed Therapy Combined with Systemic Therapy: Current Status and Future Directions.肝靶向治疗联合全身治疗：现状与未来方向
Semin Intervent Radiol. 2024 Jan 24;40(6):515-523. doi: 10.1055/s-0043-1777711. eCollection 2023 Dec.
10
Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma.免疫检查点抑制剂与局部区域治疗联合用于肝细胞癌的治疗
Cancers (Basel). 2023 Oct 20;15(20):5072. doi: 10.3390/cancers15205072.
J Clin Med. 2021 Mar 2;10(5):991. doi: 10.3390/jcm10050991.
4
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.局部区域治疗在肝癌的分子和免疫治疗时代。
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):293-313. doi: 10.1038/s41575-020-00395-0. Epub 2021 Jan 28.
5
Memory-like HCV-specific CD8 T cells retain a molecular scar after cure of chronic HCV infection.记忆样 HCV 特异性 CD8 T 细胞在慢性 HCV 感染治愈后保留分子痕迹。
Nat Immunol. 2021 Feb;22(2):229-239. doi: 10.1038/s41590-020-00817-w. Epub 2021 Jan 4.
6
Immune checkpoint inhibitors: use them early, combined and instead of TACE?免疫检查点抑制剂：早期使用、联合使用以及替代经动脉化疗栓塞术？
Gut. 2020 Oct;69(10):1887-1888. doi: 10.1136/gutjnl-2019-319658. Epub 2019 Oct 14.
7
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma.免疫激活是钇-90 放射性栓塞治疗肝细胞癌持续临床应答的基础。
Gut. 2019 Feb;68(2):335-346. doi: 10.1136/gutjnl-2017-315485. Epub 2018 Feb 13.
8
Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.肠道圆桌会议论文：肝细胞癌近期的部分进展
Gut. 2018 Feb;67(2):380-388. doi: 10.1136/gutjnl-2017-315068. Epub 2017 Nov 17.
9
Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy.免疫检查点的作用机制概述，以支持其在癌症免疫治疗中的组合的合理设计。
Ann Oncol. 2018 Jan 1;29(1):71-83. doi: 10.1093/annonc/mdx686.
10
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.干扰素-γ相关的mRNA谱可预测对PD-1阻断的临床反应。
J Clin Invest. 2017 Aug 1;127(8):2930-2940. doi: 10.1172/JCI91190. Epub 2017 Jun 26.